This topic contains a solution. Click here to go to the answer

Author Question: When a male-to-female transsexual is treated with female hormones, which of the following is the ... (Read 102 times)

serike

  • Hero Member
  • *****
  • Posts: 542
When a male-to-female transsexual is treated with female hormones, which of the following is the likely result?
 
  A) Fat deposits on the hips
  B) Breasts enlarge
  C) Facial hair growth slows down
  D) All of the above

Question 2

Peggy wants her lover Bob to have sexual intercourse with her in different positions, including rear vaginal entry. Peggy's wishes reflect
 
  a. sexual dysfunction
  b. reduced sexual desire for Bob
  c. hypersexuality
  d. a normal desire for sexual variety



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

onowka

  • Sr. Member
  • ****
  • Posts: 353
Answer to Question 1

D

Answer to Question 2

d




serike

  • Member
  • Posts: 542
Reply 2 on: Jun 22, 2018
Wow, this really help


miss_1456@hotmail.com

  • Member
  • Posts: 289
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

About 100 new prescription or over-the-counter drugs come into the U.S. market every year.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Everyone has one nostril that is larger than the other.

For a complete list of videos, visit our video library